The Role of Hypoxia in 2-Butoxyethanol–Induced Hemangiosarcoma

To understand the molecular mechanisms underlying compound-induced hemangiosarcomas in mice, and therefore, their human relevance, a systems biology approach was undertaken using transcriptomics and Causal Network Modeling from mice treated with 2-butoxyethanol (2-BE). 2-BE is a hemolytic agent that induces hemangiosarcomas in mice. We hypothesized that the hemolysis induced by 2-BE would result in local tissue hypoxia, a well-documented trigger for endothelial cell proliferation leading to hemangiosarcoma. Gene expression data from bone marrow (BM), liver, and spleen of mice exposed to a single dose (4 h) or seven daily doses of 2-BE were used to develop a mechanistic model of hemangiosarcoma. The resulting mechanistic model confirms previous work proposing that 2-BE induces macrophage activation and inflammation in the liver. In addition, the model supports local tissue hypoxia in the liver and spleen, coupled with increased erythropoeitin signaling and erythropoiesis in the spleen and BM, and suppression of mechanisms that contribute to genomic stability, events that could be contributing factors to hemangiosarcoma formation. Finally, an immunohistochemistry method (Hypoxyprobe) demonstrated that tissue hypoxia was present in the spleen and BM. Together, the results of this study identify molecular mechanisms that initiate hemangiosarcoma, a key step in understanding safety concerns that can impact drug decision processes, and identified hypoxia as a possible contributing factor for 2-BE–induced hemangiosarcoma in mice.

[1]  A. Upton,et al.  Influence of altitude on late effects of radiation in RF-Un mice: observations on survival time, blood changes, body weight, and incidence of neoplasms. , 1970, Cancer research.

[2]  A. Stern,et al.  The mechanism of oxidative hemolysis produced by phenylhydrazine. , 1977, Molecular pharmacology.

[3]  B. Tóth,et al.  Tumor induction with the N'-acetyl derivative of 4-hydroxymethyl-phenylhydrazine, a metabolite of agaritine of Agaricus bisporus. , 1978, Cancer research.

[4]  J. Huff,et al.  Carcinogenesis bioassay in rats and mice fed diets containing 2-biphenylamine hydrochloride. , 1982, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[5]  M. Ozaki,et al.  Iron release from haemosiderin and production of iron-catalysed hydroxyl radicals in vitro. , 1988, The Biochemical journal.

[6]  P. Hirth,et al.  Molecular biology of erythropoietin. , 1988, Contributions to nephrology.

[7]  R. Chhabra NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies). , 1989, National Toxicology Program technical report series.

[8]  P. Chan NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice. , 1993, Toxicity report series.

[9]  NTP Toxicology and Carcinogenesis Studies of p-Nitroaniline (CAS No. 100-01-6) in B6C3F1 Mice (Gavage Studies). , 1993, National Toxicology Program technical report series.

[10]  E. Wagner,et al.  Oncogenes in the study of endothelial cell growth and differentiation. , 1994, Seminars in cancer biology.

[11]  M. Goldberg,et al.  Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*) , 1995, The Journal of Biological Chemistry.

[12]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[13]  G. Arteel,et al.  Acute alcohol produces hypoxia directly in rat liver tissue in vivo: role of Kupffer cells. , 1996, The American journal of physiology.

[14]  NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies). , 1997, National Toxicology Program technical report series.

[15]  Review of the genotoxicity of 2-butoxyethanol. , 1997, Mutation research.

[16]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[17]  B. Ballermann,et al.  Shear stress and the endothelium. , 1998, Kidney international. Supplement.

[18]  D. Golan,et al.  Mild spherocytosis and altered red cell ion transport in protein 4. 2-null mice. , 1999, The Journal of clinical investigation.

[19]  S. Kidson,et al.  Erythropoietin production in anemia associated with experimental cancer. , 1999, Experimental hematology.

[20]  D. Tao,et al.  The application of CD71 and Hoechst33258 to staining method for sorting fetal nucleated red blood cells in the peripheral blood of pregnant women. , 2000, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[21]  H. Kerl,et al.  [Cutaneous angiosarcoma]. , 2000, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[22]  NTP Toxicology and Carcinogenesis Studies 2-Butoxyethanol (CAS NO. 111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). , 2000, National Toxicology Program technical report series.

[23]  M. Gassmann,et al.  HIF‐1 is expressed in normoxic tissue and displays an organ‐specific regulation under systemic hypoxia , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  J. Klaunig,et al.  Effects of 2-butoxyethanol on hepatic oxidative damage. , 2002, Toxicology letters.

[25]  N. Hacohen,et al.  Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. , 2002, Diabetes.

[26]  J. Pearson,et al.  Early activation of the p42/p44MAPK pathway mediates adenosine‐induced nitric oxide production in human endothelial cells: a novel calcium‐insensitive mechanism , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  J. Klaunig,et al.  Mechanisms of 2-butoxyethanol carcinogenicity: studies on Syrian Hamster Embryo (SHE) cell transformation. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  M. Udden,et al.  In vitro sub-hemolytic effects of butoxyacetic acid on human and rat erythrocytes. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  J. Klaunig,et al.  Hepatic effects of 2-butoxyethanol in rodents. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  J. Manfredi,et al.  Multiple roles of the tumor suppressor p53 , 2002, Current opinion in oncology.

[31]  B. Burgering,et al.  Cell cycle and death control: long live Forkheads. , 2002, Trends in biochemical sciences.

[32]  N. Hacohen,et al.  Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-κB activation by TNF-α is obligatory , 2002 .

[33]  A. Nyska,et al.  Toxicity and carcinogenicity of Elmiron in F344/N rats and B6C3F1 mice following 2 years of gavage administration , 2003, Archives of Toxicology.

[34]  A. Hartman,et al.  BRCA1 and p53: compensatory roles in DNA repair , 2003, Journal of Molecular Medicine.

[35]  D. Fliser,et al.  Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Rapid Communication , 2003 .

[36]  Seng H. Cheng,et al.  Hypoxia-Inducible Factor-1 Mediates Activation of Cultured Vascular Endothelial Cells by Inducing Multiple Angiogenic Factors , 2003, Circulation research.

[37]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[38]  D. Fliser,et al.  Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. , 2003, Kidney international.

[39]  C. Lacombe,et al.  Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. , 2003, Blood.

[40]  J. Haseman,et al.  Association of liver hemangiosarcoma and secondary iron overload in B6C3F1 mice--the National Toxicology Program experience. , 2004, Toxicologic pathology.

[41]  Yu Ding,et al.  Expression and purification of recombinant cytoplasmic domain of human erythrocyte band 3 with hexahistidine tag or chitin-binding tag in Escherichia coli. , 2004, Protein expression and purification.

[42]  D. Fliser,et al.  Erythropoietin regulates endothelial progenitor cells. , 2004, Blood.

[43]  Yan Zhao,et al.  BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells. , 2004, Anticancer research.

[44]  NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies). , 2004, National Toxicology Program technical report series.

[45]  W. Rathmell,et al.  HIF transcription factor expression and induction of hypoxic response genes in a retroperitoneal angiosarcoma. , 2004, Anticancer research.

[46]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[47]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[48]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[49]  H. Lodish,et al.  Identification of K-ras as the major regulator for cytokine-dependent Akt activation in erythroid progenitors in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Klaunig,et al.  Mode of action of butoxyethanol-induced mouse liver hemangiosarcomas and hepatocellular carcinomas. , 2005, Toxicology letters.

[51]  Steve Hoberman,et al.  A computational model to define the molecular causes of type 2 diabetes mellitus. , 2005, Diabetes technology & therapeutics.

[52]  J. Klaunig,et al.  Mechanisms of 2-butoxyethanol-induced hemangiosarcomas. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  Drew T. Erickson,et al.  Sox6 Directly Silences Epsilon Globin Expression in Definitive Erythropoiesis , 2005, PLoS genetics.

[54]  H. Matsubara,et al.  Erythropoietin-Mobilized Endothelial Progenitors Enhance Reendothelialization via Akt–Endothelial Nitric Oxide Synthase Activation and Prevent Neointimal Hyperplasia , 2006, Circulation research.

[55]  L. Aiello,et al.  Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation : novel mechanism for PPAR agonist ’ s effects on edema and weight gain , 2006 .

[56]  J. Modiano,et al.  Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. , 2006, Experimental hematology.

[57]  S. Baker,et al.  PTEN function in normal and neoplastic growth. , 2006, Cancer letters.

[58]  G. Dorn,et al.  Unrestrained erythroblast development in Nix−/− mice reveals a mechanism for apoptotic modulation of erythropoiesis , 2007, Proceedings of the National Academy of Sciences.

[59]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[60]  J. Opferman,et al.  NIX is required for programmed mitochondrial clearance during reticulocyte maturation , 2007, Proceedings of the National Academy of Sciences.

[61]  Steven B. Bradfute,et al.  Hematopoietic fingerprints: an expression database of stem cells and their progeny. , 2007, Cell stem cell.

[62]  Yukio Nakamura,et al.  Establishment of Mouse Embryonic Stem Cell-Derived Erythroid Progenitor Cell Lines Able to Produce Functional Red Blood Cells , 2008, PloS one.

[63]  H. Sandoval,et al.  Essential role for Nix in autophagic maturation of erythroid cells , 2008, Nature.

[64]  C. Noguchi,et al.  Survival and proliferative roles of erythropoietin beyond the erythroid lineage , 2008, Expert Reviews in Molecular Medicine.

[65]  Jaap Keijer,et al.  HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. , 2008, Carcinogenesis.

[66]  Richard P. Hill,et al.  Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.

[67]  Ilka U. Heinemann,et al.  The biochemistry of heme biosynthesis. , 2008, Archives of biochemistry and biophysics.

[68]  Liwen Chen,et al.  Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing , 2008, PloS one.

[69]  J. Pouysségur,et al.  PHDs overactivation during chronic hypoxia “desensitizes” HIFα and protects cells from necrosis , 2008, Proceedings of the National Academy of Sciences.

[70]  Yiqian Zhu,et al.  Interleukin-6 Stimulates Circulating Blood-Derived Endothelial Progenitor Cell Angiogenesis in vitro , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[71]  R. Johnson,et al.  Nonrenal regulation of EPO synthesis. , 2009, Kidney international.

[72]  A. Awada,et al.  Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives. , 2009, Critical reviews in oncology/hematology.

[73]  Ji Zhang,et al.  Role of BNIP3 and NIX in cell death, autophagy, and mitophagy , 2009, Cell Death and Differentiation.

[74]  Jörg Rahnenführer,et al.  Robert Gentleman, Vincent Carey, Wolfgang Huber, Rafael Irizarry, Sandrine Dudoit (2005): Bioinformatics and Computational Biology Solutions Using R and Bioconductor , 2009 .

[75]  J. Swenberg,et al.  Hemangiosarcoma in rodents: mode-of-action evaluation and human relevance. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[76]  Thomas Mammone,et al.  SIRT1 promotes differentiation of normal human keratinocytes. , 2009, The Journal of investigative dermatology.